Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,408,640
+$30,797,440 QoQ
Shares Held
1,672,000
+30.6% QoQ
Ownership
8.95%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#3
of 156 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,506,945,847 across 50 Biotechnology names. RIGL ranks #9 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in RIGL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,408,640 | 1,672,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $65,408,640 | 1,672,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $34,611,200 | 1,280,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $34,611,200 | 1,280,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,805,880 | 836,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,510,920 | 724,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $29,968,000 | 1,600,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,272,840 | 1,516,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,376,640 | 1,152,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,852,480 | 1,536,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,349,280 | 1,624,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,732,800 | 15,360,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,795,000 | 17,100,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,506,880 | 17,136,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $22,059,000 | 17,100,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,471,680 | 17,024,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,434,000 | 16,956,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,074,391 | 3,452,874 | Shares | Sole | 2022-11-14 | |
| 2020-06-30 | $956,541 | 522,700 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||